Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Circulation Research|July 12, 2021
PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca2+ ContentDavid C Hutchings, Charles M Pearman, George W P Madders, et al.
Physiological Reports|January 22, 2020
Chronic vagal nerve stimulation has no effect on tachycardia-induced heart failure progression or excitation-contraction couplingEmma J Radcliffe, Charles M Pearman, Amy Watkins, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 11, 2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 8, 2018
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single centerFrancesco Mazzarotto, Francesca Girolami, Beatrice Boschi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2013
Human amniotic fluid stem cell differentiation along smooth muscle lineageMarco Ghionzoli, Andrea Repele, Laura Sartiani, et al.
Circulation. Heart Failure|March 4, 2017
Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic CardiomyopathyRaffaele Coppini, Luca Mazzoni, Cecilia Ferrantini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2026
Cardiovascular pharmacotherapy in year in 2025Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
Pageof 17